Title: Case of COVID-19 Presenting as Ventricular Tachycardia
Authors: Harharpreet Kaur, Kiranjit Kaur, Manpreet Singh, Mridul Arora
DOI: https://dx.doi.org/10.18535/jmscr/v8i12.22
Abstract
SARS‐CoV‐2 primarily involves the lungs and causes respiratory symptoms. Concurrent cardiac complications have also been identified in COVID -19 infection. Cardiac injury can lead to arrhythmias by affecting the function of ion channels and cardiac action potentials. This injury may be an independent predictor for adverse outcomes .Our patient was an 82 year old male who presented with ventricular tachycardia. He was not a known cardiac patient. He did not have any clinical or ECG evidence of myocardial infarction nor any respiratory symptoms suggestive of COVID-19 infection. It could be a cardiac manifestation of COVID-19. All patients who present with clinical features suggestive of heart disease should be tested for COVID -19 .Prompt recognition and treatment of arrhythmias may be lifesaving.
Keywords: COVID-19; Myocarditis; Ventricular tachycardia.
References
- Wang et al Cardiac arrhythmias in patients with COVID‐19. Journal of Arrhythmia. 2020;36:827–836
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus‐infected pneumonia in Wuhan, China. JAMA 2020;323(11):1061.
- Chen C, Chen C, Yan J, Zhou N, Zhao JP, Wang DW. Analysis of myocardial injury in patients with COVID‐19 and association between concomitant cardiovascular diseases and severity of COVID‐19. Zhong Hua Xin Xue Guan Bing Za Zhi. 2020; 48: E008. https://doi.org/10.3760/cma.j.cn112148‐20200225‐00123
- Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID‐19). JAMA Cardiol 2020;e201017.
- Cao X. COVID‐19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20(5):269–70.